GLP-1 Agonist Use Increases the Incidence of Adhesive Capsulitis and Odds of Requiring Operative Management in Type 2 Diabetes Patients: A Matched Propensity Score Analysis.
GLP-1 受體激動劑的使用增加了2型糖尿病患者粘連性囊炎的發生率及需要手術治療的機率：一項匹配傾向得分分析。
J Shoulder Elbow Surg 2025-01-24
GLP-1 Receptor Agonist Medications Alter Outcomes of Spine Surgery: A Study Among Over 15,000 Patients.
GLP-1 受體激動劑藥物改變脊椎手術的結果：一項超過 15,000 名患者的研究。
Spine (Phila Pa 1976) 2025-02-03
The Use of Semaglutide in Patients Undergoing Lumbar Fusion Does not Increase 90-Day Medical or 1-Year Implant Complications.
Semaglutide 在接受腰椎融合手術的患者中使用不會增加90天的醫療或1年的植入併發症。
Clin Spine Surg 2025-03-17
Semaglutide Use is Associated with Higher Rates of Pseudarthrosis and Dysphagia in Patients Undergoing Posterior Cervical Fusion.
Semaglutide 使用與接受後頸椎融合手術患者中偽關節形成和吞嚥困難的較高發生率相關。
Spine J 2025-03-28
GLP-1 Agonists' Effect on Infection and Union after Tibiotalar Fusion, Subtalar Fusion, Triple Arthrodesis.
GLP-1 受體激動劑對脛距關節融合、距下關節融合及三重關節融合後感染與癒合的影響。
Foot Ankle Int 2025-03-31
The impact of semaglutide use for weight loss on transforaminal lumbar interbody fusion outcomes.
Semaglutide 用於減重對經椎間孔腰椎椎體間融合術結果的影響
Clin Neurol Neurosurg 2025-05-17
The impact of semaglutide on fusion rates following posterior lumbar fusion surgery in patients with type 2 diabetes.
Semaglutide 對第二型糖尿病患者接受後路腰椎融合手術後融合率的影響
Int J Surg 2025-05-28
Glucagon-like peptide-1 receptor agonist use prior to spinal surgery results in reduced postoperative length of stay: A propensity-score matched analysis.
脊椎手術前使用 Glucagon-like peptide-1 receptor agonist 可減少術後住院天數：傾向分數配對分析
N Am Spine Soc J 2025-06-05
Association Between Glucagon-Like Peptide-1 Receptor Agonists and Non-Fusion Risk After Single-Level Anterior Cervical Discectomy and Fusion.
GLP-1 受體促效劑與單節段前路頸椎椎間盤切除融合術後非融合風險之關聯
Spine J 2025-07-09